Product Details:
Dosage Form | Tablet |
Brand | MyHep Tablets |
Packaging Size | Pack of 28 Tablets |
Content: | Sofosbuvir |
Strength | 400 mg |
Side Effects :- Nausea, Diarrhea, Headaches, Loss of appetite, Lower back or side pain, Insomnia,Fever.
Product Details:
Packaging Type | Box |
Type Of Medicines | Allopathic |
Brand | Cipla |
Medicine Type | Allopathic |
Packing Size | 30 Tablets |
Product Details:
Packaging Size | 1x30 |
Packaging Type | Plastic Bottle, Box |
Usage | Clinic, Hospital, Personal |
Form | Tablets |
Product Details:
Minimum Order Quantity | 1 Bottle |
Dosage Form | Tablet |
Dose/Strength | 100 mg/400 mg |
Packaging Type | Box |
Form | Tablets |
Product Details:
Packaging Size | 3750 IU 5 ml Vial |
Brand | Oncaspar |
Composition | Pegaspargase |
Treatment | Cancer |
Packaging | Vial |
Dosage Form | Injection |
Prescription/Non prescription | Prescription |
Dose Strength | 750 IU /ml |
Category | CANCER |
Drug | Pegaspargase |
Generic Name | Pegaspargase |
Product Details:
Usage | Clinical, Hospital, Personal |
Product Type | API |
Dose | 5 mg/ml |
Product Details:
Minimum Order Quantity | 1 Bottle |
Dosage Form | Tablet |
Dose/Strength | 400 mg/100 mg |
Packaging Type | Box |
Product Details:
Minimum Order Quantity | 1 Unit |
Usage/Application | Hospital |
LYNPARZA is a prescription medicine used to treat women with advanced ovarian cancer who have received previous treatment with 3 or more prior chemotherapy medicines or a combination of chemotherapy medicines for their cancer, and have a certain type of abnormal inherited BRCA gene.
Your healthcare provider will perform a test to make sure that LYNPARZA is right for you.
Additional Information:
Product Details:
Dosage Form | Tablet |
Dose/Strength | 90 mg/400 mg |
Packaging Size | 28 tablets |
Product Details:
Minimum Order Quantity | 1 Unit |
Packaging Size | 125MG (21 CAPCULES) |
Brand | PALBACE |
Composition | Palbociclib |
Manufacturer | PFIZER |
Treatment | BREAT CANCER |
Prescription/Non prescription | Prescription |
Also Gives | Third Party Manufacturing |
Form | Tablet |
Additional Information:
Product Details:
Usage | Personal, Hospital, Clinical |
Dose | 150 mg |
Packaging Size | 30 Tablets |
Packaging Type | Plastic Bottle, Box |
Form | Tablets |
Side Effects:- Closing of the throat, Swelling of the lips, tongue, face or hives, Increased coughing, Fever and chest pain, Eye pain or irritation.
Product Details:
Usage | Hospital, Personal, Clinical |
Dose | 250 mg |
Product Type | Finished Product |
Brand Name | GEFTIB |
Form | Tablets |
What is GEFTIB?
Geftib containing the active ingredient gefitinib is considered a tyrosine kinase inhibitors type of medication. The medication should be used when other medicines or other types of treatment have proven to be unsuccessful to treat non small cell lung cancer. It works by interfering with the growth and spread of cancer cells to nearby tissues or their transfer to other areas of the body.
How is GEFTIB used?
Geftib is usually taken orally once per day or as directed by a doctor. The medication can be taken with or without food but should be taken with a full glass of water. Contact a doctor for the correct dosage and length of treatment as it will depend on the patients condition and their response to the therapy. If the patient cannot swallow the tablets whole, it may be dissolved in a glass of water for about 10 minutes to be taken as a liquid.
Adverse effects
Patients using Geftib may encounter unwanted side effects such as:
Product Details:
Usage | Hospital, Personal, Clinical |
Dose | 150 mg |
Packaging Size | 30 Tablets |
Drug Name:- Erlotinib
Uses:-Erleva Tablet is a first-line drug for the treatment of metastic non-small cell lung cncer. Erleva Tablet is also used as combined therapy with gemtitabine as the first line therapy for the treatment of locally-advanced inoperable, or metastatic pancreatic cancer.
Side Effects:- Burning, tingling, numbness or pain in the hands, arms, feet, or legs, cough or hoarseness, lower back or side pain, fever or chills.
Product Details:
Minimum Order Quantity | 1 Piece |
Usage | Hospital, Clinical, Commercial, Personal |
Product Type | Finished Product |
Intravenous immunoglobulin (IVIG) is a blood product administered intravenously. It contains the pooled, polyvalent, IgG antibodies extracted from the plasma of over one thousand blood donors. IVIG's effects last between 2 weeks and 3 months.
IVIG is given as a plasma protein replacement therapy (IgG) for immune deficient patients who have decreased or abolished antibody production capabilities. In these immune deficient patients, IVIG is administered to maintain adequate antibody levels to prevent infections and confers a passive immunity. Treatment is given every 3–4 weeks. In the case of patients with autoimmune disease, IVIG is administered at a high dose (generally 1-2 grams IVIG per kg body weight) to attempt to decrease the severity of the autoimmune diseases such as dermatomyositis. Currently, IVIg is being increasingly used off-label in a number of pathological conditions; the increasing world-wide usage of IVIg may lead to shortages of this beneficial drug.
IVIG is useful in some acute infection cases such as pediatric HIV infection as well as autoimmune, such as Guillain–Barré syndrome.
Side Effects: 1) Headache
2) dermatitis - usually peeling of the skin of the palms and soles.
3) acute kidney injury.
4) venous thrombosis
5) aseptic meningitis
Additional Information:
Product Details:
Usage | Clinical, Hospital |
Dose | 50mg & 100mg |
Product Type | Vial |
Brand | Dacotin |
Form | Injection |
Dacotin 50mg & 100mg ( Oxaliplatin ) Injection is a cancer medication that interferes with the growth of cancer cells and slows their growth and spread in the body. Dacotin 50mg & 100mg ( Oxaliplatin ) Injection is used together with other cancer medications to treat colon and rectal cancer
Product Details:
Dose | 45 mg |
Usage | Clinical, Hospital, Personal |
Product Type | API |
Form | Injection |
Brand Name | Wepox |
Side Effects : Hypertension, myalgia, arthralgia, flu like syndrome, rashes and urticaria, headache, confusion, generalised seizures.
Product Details:
Usage | Hospital, Personal, Clinical |
Dose | 80mg & 125mg |
Packaging Size | Pack of 30 capsules |
Types of Diseases | Breast Cancer, Ovarian Cance |
Side Effects:- Nausea, vomiting, heartburn stomach, pain, diarrhea or constipation, loss of appetite, hiccups, hair loss, headache, dizziness, tired feeling, mild skin rash, ringing in your ears, sleep problems.
Product Details:
Dose/Strength (ex. 1 mg or 1 ml) | 2 Mg & 3.5 Mg |
Usage | Clinical, Hospital |
Form | Vial |
Contains | Bortezomib |
Product Details:
Usage | Clinical, Personal, Hospital |
Packaging Size | 5x6 Tablets |
Dose | 400 mg |
Product Details:
Dose/Strength (ex. 1 mg or 1ml) | 10mg/50mg/100mg |
Packaging Type | Box |
Usage | Personal, Clinical, Hospital |
Product Details:
Usage | Hospital, Personal, Clinical |
Dose | 2 mg, 5 mg |
Form | Tablets |
Product Details:
Packaging Type | Glass Bottle, Box |
Usage | Clinical, Hospital, Personal |
Form | Injection |
The company is a highly efficient Exporter and Supplier of Farmorubicin Injection.
Uses : Epirubicin is used to treat breast cancer. It belongs to a class of drugs known as anthracyclines and works by slowing or stopping the growth of cancer cells.
Side Effects : Nausea, vomiting, diarrhoea, abdominal pain, flushing, or skin/nail colour changes, Hair loss etc
Product Details:
Usage | Clinical, Hospital |
Drug Name | Alimta 2 |
Strength | 500 mg |
Product Details:
Usage | Clinical, Hospital |
Drug Name | Nimotuzuma |
Types of Diseases | Nasopharyngeal Cancer, Head and neck Cancer |
3.6/5
Rated by 49 Users